These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...
“Incremental celebrates the strong results of our collaboration with Bayer and Skai,” said David Pollet, CEO of Incremental. “Integrating incrementally measurement directly into media activation ...
Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp.
Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the ...